CardioComm Solutions Inc. (EKG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, CardioComm Solutions Inc. (EKG) has a cash flow conversion efficiency ratio of 0.215x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-121.85K ≈ $-88.15K USD) by net assets (CA$-567.74K ≈ $-410.69K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see CardioComm Solutions Inc. market capitalisation for the company's overall valuation and market capitalisation.
CardioComm Solutions Inc. - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how CardioComm Solutions Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
CardioComm Solutions Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CardioComm Solutions Inc. ranked by their cash flow conversion efficiency. Explore CardioComm Solutions Inc. earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MT Educare Limited
NSE:MTEDUCARE
|
-0.429x |
|
Protagenic Therapeutics
NASDAQ:PTIX
|
0.087x |
|
Grupo Vasconia S.A.B
MX:VASCONI
|
0.006x |
|
Distribution Finance Capital Holdings PLC
LSE:DFCH
|
0.088x |
|
Ausmon Resources Ltd
AU:AOA
|
-0.232x |
|
Moab Minerals Ltd
AU:MOM
|
-0.120x |
|
Jiuzi Holdings Inc
NASDAQ:JZXN
|
-0.105x |
|
Direct Digital Holdings Inc
NASDAQ:DRCT
|
0.064x |
Annual Cash Flow Conversion Efficiency for CardioComm Solutions Inc. (2013–2024)
The table below shows the annual cash flow conversion efficiency of CardioComm Solutions Inc. from 2013 to 2024. View latest CardioComm Solutions Inc. stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CA$-276.58K ≈ $-200.07K |
CA$-110.66K ≈ $-80.05K |
0.400x | +273.45% |
| 2023-12-31 | CA$-504.65K ≈ $-365.06K |
CA$-54.07K ≈ $-39.11K |
0.107x | +180.05% |
| 2022-12-31 | CA$-407.32K ≈ $-294.65K |
CA$54.52K ≈ $39.44K |
-0.134x | -146.91% |
| 2021-12-31 | CA$-423.38K ≈ $-306.26K |
CA$-120.80K ≈ $-87.38K |
0.285x | +585.41% |
| 2020-12-31 | CA$-670.32K ≈ $-484.90K |
CA$39.40K ≈ $28.50K |
-0.059x | -185.08% |
| 2019-12-31 | CA$-895.81K ≈ $-648.01K |
CA$-61.89K ≈ $-44.77K |
0.069x | -97.55% |
| 2018-12-31 | CA$-68.41K ≈ $-49.49K |
CA$-192.53K ≈ $-139.27K |
2.814x | +572.08% |
| 2017-12-31 | CA$489.32K ≈ $353.96K |
CA$-291.70K ≈ $-211.01K |
-0.596x | -102.26% |
| 2016-12-31 | CA$-7.74K ≈ $-5.60K |
CA$-204.16K ≈ $-147.68K |
26.374x | +6060.44% |
| 2015-12-31 | CA$-687.89K ≈ $-497.61K |
CA$-294.50K ≈ $-213.03K |
0.428x | -44.88% |
| 2014-12-31 | CA$-595.83K ≈ $-431.02K |
CA$-462.75K ≈ $-334.75K |
0.777x | -72.03% |
| 2013-12-31 | CA$-339.45K ≈ $-245.56K |
CA$-942.44K ≈ $-681.75K |
2.776x | -- |
About CardioComm Solutions Inc.
CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. The company offers consumer health monitoring products, including GEMS mobile ECG, GEMS mobile RPM, HeartCheck CardiBeat " Mobile ECG device, and HeartCheck SMAR… Read more